StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note released on Saturday morning. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance Shares of BTX opened at $2.20 on Friday. Brooklyn ImmunoTherapeutics has a 1-year low of $0.17 and a 1-year high of $10.10. […]